Bicycle Therapeutics plc
BCYC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $536,411 | $481,301 | $587,482 | $966,724 |
| - Cash | $648,325 | $721,451 | $792,973 | $879,520 |
| + Debt | $981 | $7,197 | $8,325 | $9,493 |
| Enterprise Value | -$110,933 | -$232,953 | -$197,166 | $96,697 |
| Revenue | $11,734 | $2,920 | $9,977 | $3,708 |
| % Growth | 301.8% | -70.7% | 169.1% | – |
| Gross Profit | $11,734 | -$68,109 | -$47,294 | -$52,364 |
| % Margin | 100% | -2,332.5% | -474% | -1,412.2% |
| EBITDA | -$57,095 | -$77,433 | -$70,204 | -$65,959 |
| % Margin | -486.6% | -2,651.8% | -703.7% | -1,778.8% |
| Net Income | -$59,100 | -$78,952 | -$60,754 | -$51,854 |
| % Margin | -503.7% | -2,703.8% | -608.9% | -1,398.4% |
| EPS Diluted | -0.85 | -1.14 | -0.88 | -0.74 |
| % Growth | 25.4% | -29.5% | -18.9% | – |
| Operating Cash Flow | -$71,173 | -$72,786 | -$86,702 | -$9,360 |
| Capital Expenditures | -$674 | -$498 | -$606 | -$368 |
| Free Cash Flow | -$71,847 | -$73,284 | -$87,308 | -$9,764 |